Tuesday, April 28, 2026

#antibody-drug conjugates

3 articles

Oncology Biotech Stocks Face Critical Q3-Q4 2026 FDA Decisions Clustering Around Novel Drug Mechanisms

Biotech Equities

Oncology Biotech Stocks Face Critical Q3-Q4 2026 FDA Decisions Clustering Around Novel Drug Mechanisms

Salvado•Apr 18, 2026

FDA Priority Review for B7-H3 Antibody Drug Conjugate Accelerates Biotech Market Activity

Healthcare Sector Trading

FDA Priority Review for B7-H3 Antibody Drug Conjugate Accelerates Biotech Market Activity

Salvado•Apr 16, 2026

Precision Oncology Stocks Poised for Catalyst-Rich Quarter as Multiple Biotech Firms Race Toward Regulatory Milestones

Biotech & Pharma Stocks

Precision Oncology Stocks Poised for Catalyst-Rich Quarter as Multiple Biotech Firms Race Toward Regulatory Milestones

ViaNews Editorial Team (Markets)•Feb 15, 2026